Question special

With the potential to test for every gene polymorphism and report a person's risk for adverse health events, will the definition of disease change from a "yes/no" risk report to a sliding scale of risk levels? How can we expect to see preventive medicine augment patients' care relative to genetic predisposition? Can randomized controlled trials keep up with preventive interventions?